Table 4 Laboratory investigations of the included patients.

From: Clinical characteristics of human fascioliasis in Egypt

Variable

Baseline median (IQR)

Follow-up median (IQR)

P-value

Fasciola antibody titer

640 (80–1280)

160.0 (40.0–1280.0)

0.000*

White blood cells (109/L)

12 (2.3–45)

8 (3–23)

0.000*

Hemoglobin gm/dl (mean ± SD)

12.10 ± 1.55

12.20 ± 1.34

0.064

Platelets (109/L)

304 (110–888)

295(124–633)

0.018*

Eosinophil count (109/L)

3.6 (0–32.9)

0.7 (0–10.1)

0.000*

Eosinophil percent

34 (1.0–85)

9(1.0–53)

0.000*

Total bilirubin (mg/dl)

2.6 (0.3–11)

1 (0.4–2.1)

0.000*

Direct bilirubin (mg/dl)

1.6 (0.1–9)

0.4 (0.1–1.3)

0.000*

ALT (U/L)

56 (14–311)

32 (15–208)

0.000*

AST (U/L)

59 (19.5–287)

33 (17–101)

0.000*

Albumin (gm/dl) (mean ± SD)

4.02 ± 0.45

4.01 ± 0.36

0.637

Alkaline phosphatase (U/L)

327 (67 -923)

231.5 (45 -431)

0.000*

  1. The asterisk means statistically significant. White blood cells (4–10), Hemoglobin (11.7–15.5), Platelets (150- 440), Eosinophil count (0–0.8), Eosinophil percent (0–3), Fasciola Antibody titer (negative: Less than 160, positive: 160 or more), Total Bilirubin (0–1.2), ALT (0–41), AST (0 -40), Serum Albumin (3.5–5.2), Alkaline phosphatase (44–147).
  2. ALT alanine transaminase, AST aspartate transaminase.
Back to article page